SL Green & Vornado Complete $1.2 Billion Refinancing of 280 Park Avenue
Aug 24, 2017 12:50 pm UTC| Business
NEW YORK, Aug. 24, 2017 -- SL Green Realty Corp. (NYSE:SLG) and Vornado Realty Trust (NYSE:VNO) today announced that they have closed a $1.2 billion refinancing of 280 Park Avenue, a premier 1,250,000 square foot...
Innovest Global Inc. Announces Former “C” Level Executive From Fortune 500 Company
Aug 24, 2017 12:40 pm UTC| Business
CLEVELAND, Aug. 24, 2017 -- Innovest Global Inc. (OTC PINK:IVST) announces that Mike Yukich will be joining the management team as the Chief Financial Officer for consolidated holding company operations. Dan Martin,...
Aug 24, 2017 12:40 pm UTC| Business
Winterthur, Delaware, Aug. 24, 2017 -- Celebrate inspiration and elegance at Winterthur’s 54th Annual Delaware Antiques Show, a spectacular showcase of art, antiques, and design featuring 60 exceptional dealers,...
Chief Financial Officer Harold Telners Joins CGE Energy’s Executive Team
Aug 24, 2017 12:38 pm UTC| Business
BRIGHTON, Mich., Aug. 24, 2017 -- CGE Energy (OTCPink:CGEI), the leading engineer of no capital cost energy solutions, announces that Mr. Harold Telners, a Certified Public Accountant, and seasoned financial executive,...
Arkema supports U.S. Appeals Court ruling on EPA SNAP authority
Aug 24, 2017 12:30 pm UTC| Business
King of Prussia, PA, Aug. 24, 2017 -- The Court stated that EPA’s legal right to regulate replacement refrigerants under SNAP is limited to their effect on ozone depletion not global warming potential. The delisting of...
Sarepta Therapeutics to Present at Three Upcoming Investor Conferences
Aug 24, 2017 12:30 pm UTC| Business
CAMBRIDGE, Mass., Aug. 24, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare...
Humanigen Announces up to $15 Million Committed Equity Financing Facility
Aug 24, 2017 12:30 pm UTC| Business
BRISBANE, Calif., Aug. 24, 2017 -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced it has signed an agreement for a...